A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder

被引:31
|
作者
de Beaurepaire, Renaud [1 ]
机构
[1] Grp Hosp Paul Guiraud, Villejuif, France
来源
FRONTIERS IN PSYCHIATRY | 2018年 / 9卷
关键词
GABA receptor b; reward network; amygdala; Pavlovian associations; substitution; (morphine; methadone; buprenorphin); HIGH-DOSE BACLOFEN; VENTRAL TEGMENTAL AREA; GABA-B RECEPTOR; POSITIVE ALLOSTERIC MODULATOR; MESOLIMBIC DOPAMINE SYSTEM; TERM ABSTINENT ALCOHOLICS; RESTING-STATE SYNCHRONY; CENTRAL-NERVOUS-SYSTEM; PREFERRING SP RATS; BINGE-LIKE ETHANOL;
D O I
10.3389/fpsyt.2018.00506
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Baclofen, a GABA-B receptor agonist, is a promising treatment for alcohol use disorder (AUD). Its mechanism of action in this condition is unknown. GABA-B receptors interact with many biological systems potentially involved in AUD, including transduction pathways and neurotransmitter systems. Preclinical studies have shown that GABA-B receptors are involved in memory storage and retrieval, reward, motivation, mood and anxiety; neuroimaging studies in humans show that baclofen produces region-specific alterations in cerebral activity; GABA-B receptor activation may have neuroprotective effects; baclofen also has anti-inflammatory properties that may be of interest in the context of addiction. However, none of these biological effects fully explain the mechanism of action of baclofen in AUD. Data from clinical studies have provided a certain number of elements which may be useful for the comprehension of its mechanism of action: baclofen typically induces a state of indifference toward alcohol; the effective dose of baclofen in AUD is extremely variable from one patient to another; higher treatment doses correlate with the severity of the addiction; many of the side effects of baclofen resemble those of alcohol, raising the possibility that baclofen acts as a substitution drug; usually, however, there is no tolerance to the effects of baclofen during long-term AUD treatment. In the present article, the biological effects of baclofen are reviewed in the light of its clinical effects in AUD, assuming that, in many instances, clinical effects can be reliable indicators of underlying biological processes. In conclusion, it is proposed that baclofen may suppress the Pavlovian association between cues and rewards through an action in a critical part of the dopaminergic network (the amygdala), thereby normalizing the functional connectivity in the reward network. It is also proposed that this action of baclofen is made possible by the fact that baclofen and alcohol act on similar brain systems in certain regions of the brain.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Baclofen for alcohol use disorder: Mechanisms, results and safety
    Dehanov, S.
    Oliveira, C.
    Ferreira, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S316 - S316
  • [2] Baclofen for alcohol use disorder
    Minozzi, Silvia
    Saulle, Rosella
    Rosner, Susanne
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (11):
  • [3] Baclofen for alcohol use disorder
    Agabio, R.
    Saulle, R.
    Rosner, S.
    Minozzi, S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (01):
  • [4] SEX AS A POTENTIAL MODERATOR FOR BACLOFEN RESPONSE IN THE TREATMENT OF ALCOHOL USE DISORDER
    Morley, K. C.
    Logge, W.
    Louie, E.
    Hurzeler, T.
    Baillie, A.
    Haber, P.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 169A - 169A
  • [5] The Impact of Alcohol Use Disorder on Tuberculosis: A Review of the Epidemiology and Potential Immunologic Mechanisms
    Wigger, Gregory W.
    Bouton, Tara C.
    Jacobson, Karen R.
    Auld, Sara C.
    Yeligar, Samantha M.
    Staitieh, Bashar S.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Editorial: Baclofen in the Treatment of Alcohol Use Disorder
    de Beaurepaire, Renaud
    Heydtmann, Mathis
    Agabio, Roberta
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [7] Assessing Alcohol Versus Baclofen Withdrawal Syndrome in Patients Treated With Baclofen for Alcohol Use Disorder
    Rolland, Benjamin
    Jaillette, Emmanuelle
    Carton, Louise
    Bence, Camille
    Deheul, Sylvie
    Saulnier, Fabienne
    Bordet, Regis
    Cottencin, Olivier
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (01) : 153 - 156
  • [8] Baclofen for the treatment of alcohol use disorder: the Cagliari Statement
    Agabio, Roberta
    Sinclair, Julia M. A.
    Addolorato, Giovanni
    Aubin, Henri-Jean
    Beraha, Esther M.
    Caputo, Fabio
    Chick, Jonathan D.
    de La Selle, Patrick
    Franchitto, Nicolas
    Garbutt, James C.
    Haber, Paul S.
    Heydtmann, Mathis
    Jaury, Philippe
    Lingford-Hughes, Anne R.
    Morley, Kirsten C.
    Mueller, Christian A.
    Owens, Lynn
    Pastor, Adam
    Paterson, Louise M.
    Pelissier, Fanny
    Rolland, Benjamin
    Stafford, Amanda
    Thompson, Andrew
    van den Brink, Wim
    de Beaurepaire, Renaud
    Leggio, Lorenzo
    LANCET PSYCHIATRY, 2018, 5 (12): : 957 - 960
  • [9] Incorporating ondansetron and baclofen in alcohol use disorder treatment
    Ross, Hayley
    Harries, Bruce
    Szelest, Izabela
    Engelbrecht, Roland
    Umhau, John C.
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2023, 25 (03) : 253 - 254
  • [10] Incorporating ondansetron and baclofen in alcohol use disorder treatment
    Hayley Ross
    Bruce Harries
    Izabela Szelest
    Roland Engelbrecht
    John C. Umhau
    Canadian Journal of Emergency Medicine, 2023, 25 : 253 - 254